This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.Hypertension affects more than 50 million Americans and comes with enormous annual economic and social costs. Hypertension is associated with significant increased risk for stroke and atherosclerosis. In addition to elevated blood pressure, hypertension is characterized by neuroendocrine and immune activation and cell adhesion molecule activation, including elevated levels of C-reactive protein (CRP), inflammatory cytokines interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha), and soluble adhesion molecules intercellular adhesion molecule-1 (sICAM-1) (CD54) and E-selectin (sCD62E), which are predictive of morbidity and mortality outcomes. Pharmacological treatment for hypertension successfully reduces blood pressure, but has limited effectiveness for reducing accompanying inflammation and its associated morbidity and mortality. Exercise and diet interventions have been shown to significantly reduce blood pressure, but few if any studies have examined effects on inflammation in hypertension or potential mechanisms. We will examine the effects of a 12-week exercise intervention and a 12-week exercise plus diet intervention on inflammation and cell adhesion in 150 patients with hypertension (blood pressure 140/90 mm Hg but 120/80 mm Hg but 140/90 mm Hg) who are currently not on anti-hypertensive medication. Prior to and following the interventions, we will assess resting and stress-induced (mental stressor and treadmill exercise testing) changes in circulating levels of CRP, IL-6, TNF-alpha, sICAM-1, sE-selectin, expression of the 2-integrin subunits CD11a and CD11b on leukocytes, leukocyte activation (pseudopod formation), and peripheral blood mononuclear cell (PBMC) chemotaxis.Hypothesis 1. Compared to a 12-week wait-list control group, the 12-week exercise intervention, and especially the 12-week exercise plus diet intervention, will reduce resting and stress-induced inflammation and cell adhesion.1-1. Intervention groups will exhibit reduced levels of CRP, IL-6, TNF-alpha, sICAM-1, sE-selectin, leukocyte CD11a and CD11b expression, leukocyte activation, chemotaxis at rest pre to post intervention as compared to the wait list control group.1-2. Intervention groups will exhibit reduced levels of CRP, IL-6, TNF-alpha, sICAM-1, sE-selectin, leukocyte CD11a and CD11b expression, leukocyte activation, and chemotaxis in response to the acute challenges pre to post intervention as compared to the wait list control group.Hypothesis 2. Compared to a 12-week wait-list control group, the 12-week exercise intervention, and especially the 12-week exercise plus diet intervention, will increase fitness levels, reduce urinary catecholamine and cortisol levels, and increase insulin sensitivity. [These hypothesized effects, while relatively straightforward and expected, need to be verified in order the test the mechanisms proposed in Hypothesis 3 below.]2.1 Both exercise and exercise plus diet groups will show increased fitness levels as compared to the wait list control group.2.2 Both exercise and exercise plus diet groups will show increased insulin sensitivity and decreased catecholamine and cortisol levels as compared to the wait list control group.2.3 The exercise plus diet group will show greater weight reduction as compared to the exercise intervention or the wait list control group.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
5M01RR000827-32
Application #
7606595
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Project Start
2006-12-01
Project End
2007-11-30
Budget Start
2006-12-01
Budget End
2007-11-30
Support Year
32
Fiscal Year
2007
Total Cost
$13,567
Indirect Cost
Name
University of California San Diego
Department
Type
Schools of Medicine
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Lavigne, Katie M; Woodward, Todd S (2018) Hallucination- and speech-specific hypercoupling in frontotemporal auditory and language networks in schizophrenia using combined task-based fMRI data: An fBIRN study. Hum Brain Mapp 39:1582-1595
Milot, Marie-Hélène; Marchal-Crespo, Laura; Beaulieu, Louis-David et al. (2018) Neural circuits activated by error amplification and haptic guidance training techniques during performance of a timing-based motor task by healthy individuals. Exp Brain Res 236:3085-3099
Hsu, Simon; Rifkin, Dena E; Criqui, Michael H et al. (2018) Relationship of femoral artery ultrasound measures of atherosclerosis with chronic kidney disease. J Vasc Surg 67:1855-1863.e1
Inker, Lesley A; Grams, Morgan E; Levey, Andrew S et al. (2018) Relationship of Estimated GFR and Albuminuria to Concurrent Laboratory Abnormalities: An Individual Participant Data Meta-analysis in a Global Consortium. Am J Kidney Dis :
Egnot, Natalie Suder; Barinas-Mitchell, Emma; Criqui, Michael H et al. (2018) An exploratory factor analysis of inflammatory and coagulation markers associated with femoral artery atherosclerosis in the San Diego Population Study. Thromb Res 164:9-14
Juraschek, Stephen P; Miller 3rd, Edgar R; Appel, Lawrence J (2018) Orthostatic Hypotension and Symptoms in the AASK Trial. Am J Hypertens 31:665-671
Grams, Morgan E; Sang, Yingying; Ballew, Shoshana H et al. (2018) Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate. Kidney Int 93:1442-1451
Chen, Teresa K; Appel, Lawrence J; Grams, Morgan E et al. (2017) APOL1 Risk Variants and Cardiovascular Disease: Results From the AASK (African American Study of Kidney Disease and Hypertension). Arterioscler Thromb Vasc Biol 37:1765-1769
Juraschek, Stephen P; Appel, Lawrence J; Miller 3rd, Edgar R (2017) Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. Am J Hypertens 30:871-875
Chen, Teresa K; Tin, Adrienne; Peralta, Carmen A et al. (2017) APOL1 Risk Variants, Incident Proteinuria, and Subsequent eGFR Decline in Blacks with Hypertension-Attributed CKD. Clin J Am Soc Nephrol 12:1771-1777

Showing the most recent 10 out of 1825 publications